¶ WDR7 Protein — WD Repeat Domain 7
| WDR7 Protein |
|---|
| Protein Name | WD Repeat Domain 7 |
| Gene | [WDR7](/genes/wdr7) |
| UniProt ID | Q9Y2G1 |
| PDB ID | Predicted (AlphaFold) |
| Molecular Weight | 205 kDa (1732 aa) |
| Subcellular Localization | Cytoplasm, Synaptic vesicles, Secretory granules |
| Protein Family | WD40 repeat protein family |
| Expression | High in brain, particularly cerebellum and spinal cord |
WDR7 (WD Repeat Domain 7) is a large scaffolding protein belonging to the WD40 repeat protein family. With a molecular weight of approximately 205 kDa and containing 1732 amino acids, WDR7 is characterized by multiple WD40 repeats that form a β-propeller structure. This structure enables WDR7 to serve as a versatile scaffold protein, interacting with multiple protein partners and organizing signaling complexes.
WDR7 is highly expressed in the nervous system, particularly in motor neurons, cerebellar Purkinje cells, and various brain regions. The protein plays critical roles in synaptic vesicle trafficking, neuroendocrine secretion, dopamine release, and synaptic plasticity. Its functions at the synapse make it essential for normal neuronal communication, and dysfunction of WDR7 has been directly linked to amyotrophic lateral sclerosis (ALS) and other neurological disorders.
The discovery of WDR7 variants causing autosomal recessive ALS represents a significant advance in understanding the genetic basis of motor neuron disease. WDR7 joins a growing list of genes involved in vesicle trafficking and synaptic function that are implicated in neurodegeneration.
WDR7 is a large protein with a complex domain architecture:
¶ Domain Architecture
-
N-terminal Domain: Contains proline-rich regions that mediate protein-protein interactions with SH3 domain-containing proteins.
-
Multiple WD40 Repeats (7-8): The defining feature of WDR7. Each WD40 repeat consists of approximately 40-60 amino acids forming a conserved β-propeller blade. Seven to eight such repeats are arranged in a circular β-propeller structure that serves as a platform for protein interactions.
-
C-terminal Region: Contains additional regulatory sequences and interaction motifs.
- β-Propeller Structure: The WD40 repeats fold into a seven-bladed β-propeller, providing a large interaction surface for binding multiple partners simultaneously.
- Scaffold Capacity: The multiple interaction sites allow WDR7 to organize multi-protein complexes involved in vesicle trafficking and signaling.
- Flexibility: The extended structure allows WDR7 to connect different components of the synaptic machinery.
- Phosphorylation: Multiple serine/threonine phosphorylation sites regulate protein-protein interactions
- Ubiquitination: Controls protein stability and turnover
- Sumoylation: May regulate subcellular localization
WDR7 plays a central role in synaptic vesicle dynamics:
- Vesicle Docking: Facilitates proper positioning of synaptic vesicles at the active zone
- Vesicle Maturation: Participates in synaptic vesicle preparation for release
- Recycling: Involved in vesicle recycling after exocytosis
- Neurotransmitter Release: Critical for normal quantal neurotransmitter release
¶ Neuropeptide and Hormone Secretion
In neuroendocrine cells, WDR7 regulates:
- Dense-Core Vesicle Trafficking: Controls movement of peptide-containing granules
- Activity-Dependent Secretion: Couples cellular activation to secretion
- Secretory Granule Maturation: Ensures proper processing and packaging of neuropeptides
WDR7 contributes to overall synaptic health:
- Synaptic Plasticity: Involved in both short-term and long-term plasticity mechanisms
- Dendritic Spine Morphology: Regulates spine shape and density
- Postsynaptic Density Organization: Helps organize postsynaptic signaling complexes
As a scaffold protein, WDR7:
- Organizes Signaling Complexes: Brings together kinases, phosphatases, and their substrates
- Spatial Regulation: Localizes signaling components to specific subcellular compartments
- Temporal Control: Modulates the kinetics of signaling events
WDR7 is directly implicated in ALS pathogenesis:
- Autosomal Recessive ALS: Biallelic loss-of-function variants in WDR7 cause ALS in affected families .
- Variant Spectrum: Nonsense and frameshift mutations leading to protein truncation have been identified.
- Population Frequency: WDR7 is considered a recessive ALS gene with incomplete penetrance.
- Mitochondrial Dysfunction: WDR7 loss leads to impaired mitochondrial function and energy metabolism in motor neurons .
- Autophagy Defects: Impaired autophagy contributes to accumulation of damaged proteins and organelles .
- Synaptic Dysfunction: Disrupted vesicle trafficking leads to impaired neurotransmitter release.
- Motor Neuron Vulnerability: Motor neurons show particular sensitivity to WDR7 deficiency.
flowchart TD
A["WDR7 Loss"] --> B["Mitochondrial<br>Dysfunction"]
A --> C["Autophagy<br>Impairment"]
A --> D["Synaptic Vesicle<br>Trafficking Defects"]
B --> E["ATP Depletion"]
C --> F["Protein Aggregate<br>Accumulation"]
D --> G["Neurotransmitter<br>Release Defects"]
E --> H["Motor Neuron<br>Death"]
F --> H
G --> H
H --> I["ALS Phenotype"]
WDR7 variants are associated with:
- Intellectual Disability: Developmental delay and cognitive impairment
- Speech and Language Delays: Particularly affecting expressive language
- Motor Development: Delayed achievement of motor milestones
- Behavioral Features: Autism spectrum traits in some patients
WDR7 may play a role in PD through:
- Dopamine Release: Regulation of dopaminergic vesicle trafficking
- Synaptic Function: Impaired synaptic plasticity in dopaminergic neurons
WDR7 deficiency leads to mitochondrial dysfunction through:
- Impaired Mitochondrial Dynamics: Altered mitochondrial fission/fusion
- Reduced ATP Production: Decreased cellular energy
- Increased Reactive Oxygen Species (ROS): Oxidative stress
- Mitochondrial Permeability Transition: Pore opening and cell death
WDR7 regulates autophagy through:
- Autophagosome Formation: Impaired nucleation
- Lysosomal Fusion: Reduced clearance
- Protein Aggregate Accumulation: Toxic inclusions
- Organelle Turnover: Defective mitophagy
Vesicle trafficking defects lead to:
- Reduced Neurotransmitter Release: Impaired synaptic transmission
- Synaptic Plasticity Deficits: Learning and memory impairments
- Excitotoxicity: Altered glutamate handling
- Synapse Loss: Structural decline
WDR7 interacts with multiple proteins involved in synaptic function:
| Partner |
Interaction Type |
Function |
| Rab proteins |
Direct binding |
Vesicle trafficking |
| SNAP-25 |
Direct binding |
Exocytosis |
| Synaptotagmin |
Direct binding |
Calcium sensing |
| Munc18 |
Direct binding |
Vesicle priming |
| CAPS |
Direct binding |
Dense-core vesicle release |
| PI4KB |
Direct binding |
Phospholipid metabolism |
| VAMP2 |
Direct binding |
Vesicle fusion |
-
Gene Therapy:
- Viral vector-mediated WDR7 expression
- CRISPR-based gene correction
- Antisense oligonucleotides
-
Small Molecule Strategies:
- Mitochondrial protectants
- Autophagy modulators
- Synaptic function enhancers
-
Symptomatic Treatments:
- Neuroprotective agents
- Antioxidants
- Metabolic support
- Protein Size: Large size complicates delivery
- Scaffold Function: Targeting scaffold proteins is complex
- CNS Delivery: Blood-brain barrier penetration
- Genetic Studies: Identifying additional WDR7 variants and modifiers
- Mechanistic Studies: Elucidating downstream pathways
- Therapeutic Development: Small molecules and gene therapy
- Biomarkers: Disease progression markers
- Understanding tissue-specific vulnerability
- Developing delivery systems for large proteins
- Exploring combination therapies